VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RNR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RNRRenaissanceRe Holdings Ltd.
$323.69$13.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRNRQuarterly Financials

RenaissanceRe Holdings Ltd. (RNR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

RenaissanceRe Holdings Ltd. (RNR) quarterly income statement — complete revenue, gross profit & net income history

RNR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue2.19B2.92B3.19B3.19B3.45B2.28B3.97B2.82B2.59B3.22B1.83B1.85B2.2B2.02B1.28B859.59M882.81M1.39B1.54B1.47B
Revenue Growth %-36.43%28.32%-19.72%13.15%33.55%-29.34%117.41%52.58%17.75%59.49%42.06%114.7%148.7%45.47%-16.54%-41.47%1.77%-0.52%16.02%-4.6%
Medical Costs & Claims0951.14M1.54B1.68B3.39B2.16B2.06B1.95B1.8B1.57B1.29B1.35B1.23B1.24B2.39B1.07B1.22B1.02B2.13B805.61M
Medical Cost Ratio %0%32.53%48.3%52.87%98.22%94.87%52.01%69.39%69.51%48.81%70.53%73.35%56.18%61.14%185.68%124.18%138%73.74%138.11%54.86%
Gross Profit01.97B1.65B1.5B61.47M116.86M1.9B861.99M788.25M1.65B537.82M491.77M962.11M785.85M-1.1B-207.89M-335.43M365.03M-586.7M662.94M
Gross Margin %0%67.47%51.7%47.13%1.78%5.13%47.99%30.61%30.49%51.19%29.47%26.65%43.82%38.86%-85.68%-24.18%-38%26.26%-38.11%45.14%
Gross Profit Growth %-100%1588.36%-13.5%74.19%-92.2%-92.92%254.04%75.28%-18.07%110.08%148.86%336.56%386.83%115.28%-87.63%-131.36%-25.71%41.73%-445.88%-16.66%
Operating Expenses0709.35M166.52M160.98M132.25M199.99M169.43M154.22M154.41M216.55M112M111.06M92.92M87.11M85.31M89.38M98.75M58.14M75.81M71.43M
OpEx / Revenue %0%24.26%5.23%5.05%3.83%8.78%4.27%5.48%5.97%6.71%6.14%6.02%4.23%4.31%6.64%10.4%11.19%4.18%4.92%4.86%
Depreciation & Amortization00-6.72M5.42M3.73M6.85M225.62M9.96M16.03M-13.69M-47.84M-40.28M-32.95M-25.73M-10.8M18.92M-9.34M-4.57M-8.49M-9.67M
Combined Ratio %0%56.78%53.52%57.93%102.05%103.65%56.28%74.87%75.48%55.52%76.67%79.37%60.41%65.44%192.32%134.58%149.18%77.92%143.04%59.72%
Operating Income13.75K1.26B1.48B1.34B-70.79M-83.13M1.73B707.77M633.84M1.43B425.82M380.72M869.19M698.74M-1.19B-297.27M-434.19M306.89M-662.5M591.51M
Operating Margin %0%43.22%46.48%42.07%-2.05%-3.65%43.72%25.13%24.52%44.48%23.33%20.63%39.59%34.56%-92.32%-34.58%-49.18%22.08%-43.04%40.28%
Operating Income Growth %100.02%1620.21%-14.65%89.41%-111.17%-105.8%307.37%85.9%-27.08%105.27%135.9%228.07%300.19%127.68%-79.04%-150.26%-24.05%68.89%-1101.59%-19.16%
EBITDA13.75K1.3B1.47B1.35B-67.05M-76.28M1.96B717.73M649.87M1.42B377.99M340.43M836.24M673.01M-1.2B-278.35M-443.52M302.32M-671M581.84M
EBITDA Margin %0%44.29%46.27%42.24%-1.94%-3.35%49.4%25.49%25.14%44.05%20.71%18.45%38.09%33.28%-93.16%-32.38%-50.24%21.75%-43.59%39.62%
Interest Expense31.79M31.39M30.58M31.79M27.09M23.25M23.81M23.61M23.1M23.2M22.95M14.89M12.13M12.38M12.1M11.89M11.96M11.87M11.92M11.83M
Non-Operating Income0-31.39M-30.58M-31.79M-27.09M-23.25M-23.81M-23.61M-23.1M-23.2M-22.95M-14.89M-12.13M-12.38M-12.1M-11.89M-11.96M-11.87M-11.92M-11.83M
Pretax Income548.81M1.26B1.48B1.34B-70.79M-83.13M1.73B707.77M633.84M1.43B425.82M380.72M869.19M698.74M-1.19B-297.27M-434.19M306.89M-662.5M591.51M
Pretax Margin %25%43.22%46.48%42.07%-2.05%-3.65%43.72%25.13%24.52%44.48%23.33%20.63%39.59%34.56%-92.32%-34.58%-49.18%22.08%-43.04%40.28%
Income Tax-32.98M116.13M148.86M176.87M-45.52M-63.91M102.01M-20.85M15.37M-554.21M9.29M5.94M28.9M5.41M2.81M-30.53M-36.71M18.62M-23.63M13.86M
Effective Tax Rate %-6.01%9.19%10.05%13.19%64.31%76.88%5.88%-2.95%2.43%-38.64%2.18%1.56%3.33%0.77%-0.24%10.27%8.45%6.07%3.57%2.34%
Net Income581.8M760.48M916.51M835.35M169.99M-189.66M1.18B503.89M373.64M1.59B202.83M199.87M572.91M456.94M-816.5M-316.07M-385.57M219.76M-440.38M464.11M
Net Margin %26.51%26.01%28.77%26.22%4.92%-8.32%29.8%17.89%14.45%49.17%11.11%10.83%26.09%22.6%-63.55%-36.77%-43.68%15.81%-28.61%31.6%
Net Income Growth %242.25%500.97%-22.49%65.78%-54.5%-111.96%482.99%152.11%-34.78%246.99%124.84%163.24%248.59%107.93%-85.41%-168.1%-35.93%11.5%-899.41%-20.41%
EPS (Diluted)6.5716.7519.4017.203.27-3.8922.629.416.9430.423.808.1519.5416.16-27.75-7.53-9.174.65-9.539.35
EPS Growth %100.92%530.59%-14.24%82.78%-52.88%-112.79%495.26%15.46%-64.48%88.24%113.69%208.23%313.09%247.53%-191.19%-180.53%-60.31%24.33%-1113.83%-25.97%
EPS (Basic)6.6016.7519.4717.253.29-3.8922.689.446.9630.503.818.1719.6016.20-27.75-7.53-9.174.65-9.539.36
Diluted Shares Outstanding42.63M44.87M47.27M47.9M51.1M50.43M51.1M51.81M51.83M51.07M50.36M45.99M43.01M42.91M42.84M43.17M43.36M44.75M46.22M48.23M